Literature DB >> 6423781

Blood-brain barrier disruption in immature Fischer 344 rats.

D E Bullard, D D Bigner.   

Abstract

Methods for transiently disrupting the blood-brain barrier (BBB) which are consistent with survival are described for immature Fischer 344 rats weighing 40 to 99 gm. A catheter was retrogradely inserted into the external carotid artery to the level of the bifurcation. Perfusion of 1.4 M mannitol or 1.6 M arabinose, at a rate of 0.01 to 0.1 ml/sec for 30 seconds, resulted in transient BBB disruption as measured by Evans blue dye (EBD) staining. Higher flow rates or perfusion with 10% to 30% dimethyl sulfoxide were associated with a mortality rate ranging from 0% to 44%. Perfusion with 0.9% sodium chloride or intrafemoral artery perfusion with 1.4 M mannitol did not disrupt the BBB. Optimum BBB disruption as measured by EBD staining was achieved with 1.6 M arabinose at 0.026 ml/sec for 30 seconds, at which time all of the 42 experimental animals had BBB disruption; all of the animals so treated survived 2 weeks following perfusion. This technique will allow the efficacy of delivering chemotherapeutic agents following BBB disruption to be tested in several of the more commonly used small-animal models for brain-tumor research.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6423781     DOI: 10.3171/jns.1984.60.4.0743

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  7 in total

Review 1.  Intra-arterial chemotherapy for malignant gliomas: a critical analysis.

Authors:  J-K Burkhardt; H A Riina; B J Shin; J A Moliterno; C P Hofstetter; J A Boockvar
Journal:  Interv Neuroradiol       Date:  2011-10-17       Impact factor: 1.610

Review 2.  Super selective intra-arterial cerebral infusion of modern chemotherapeutics after blood-brain barrier disruption: where are we now, and where we are going.

Authors:  Randy S D'Amico; Deepak Khatri; Noah Reichman; Nitesh V Patel; Tamika Wong; Sherese R Fralin; Mona Li; Jason A Ellis; Rafael Ortiz; David J Langer; John A Boockvar
Journal:  J Neurooncol       Date:  2020-02-19       Impact factor: 4.130

3.  Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article.

Authors:  John A Boockvar; Apostolos J Tsiouris; Christoph P Hofstetter; Ilhami Kovanlikaya; Sherese Fralin; Kartik Kesavabhotla; Stephen M Seedial; Susan C Pannullo; Theodore H Schwartz; Philip Stieg; Robert D Zimmerman; Jared Knopman; Ronald J Scheff; Paul Christos; Shankar Vallabhajosula; Howard A Riina
Journal:  J Neurosurg       Date:  2010-10-22       Impact factor: 5.115

4.  Enhancement of ketoconazole penetration across the blood-brain barrier of mice by dimethyl sulfoxide.

Authors:  P C Iwen; N G Miller
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

5.  Intra-arterial mannitol infusion in the chemotherapy for malignant brain tumors.

Authors:  Y Iwadate; H Namba; T Saegusa; K Sueyoshi
Journal:  J Neurooncol       Date:  1993-02       Impact factor: 4.130

6.  3D optical/CT as a preclinical companion imaging platform for glioblastoma drug development.

Authors:  Andrei Molotkov; Mikhail Doubrovin; Nikunj Bhatt; Fang-Chi Hsu; Amanda Beserra; Rajiv Chopra; Akiva Mintz
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

7.  Pleomorphic malignant fibrous histiocytoma: response of bone, lung, and brain metastases to chemotherapy.

Authors:  Manabu Hoshi; Masatsugu Takami; Makoto Ieguchi
Journal:  Radiat Med       Date:  2008-10-31
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.